| 000 | 01307 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517032754.0 | ||
| 264 | 0 | _c20160404 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1477-092X | ||
| 024 | 7 |
_a10.1177/1078155215585191 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAgilli, Mehmet | |
| 245 | 0 | 0 |
_aRe: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315. _h[electronic resource] |
| 260 |
_bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _cAug 2015 |
||
| 300 |
_a317-8 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
| 650 | 0 | 4 |
_aChemotherapy, Adjuvant _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMetabolic Syndrome _xchemically induced |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aAydin, Fevzi Nuri | |
| 773 | 0 |
_tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _gvol. 21 _gno. 4 _gp. 317-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/1078155215585191 _zAvailable from publisher's website |
| 999 |
_c24905700 _d24905700 |
||